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Abstract
Background:  The association between toxoplasmosis and psychiatric disorders has been
reported in a few anecdotal reports.
Case Presentation: A case of depression with toxoplasma seropositivity is presented. The
patient with depression showed poor response to antidepressants, for which he was investigated
and was found positive on the serological test for the toxoplasma. The response to antidepressant
treatment improved only after adequate treatment for toxoplasma.
Conclusions: The case suggests a probable association between toxoplasmosis and depression.
Background
There have been only a few case reports associating toxo-
plasmosis and psychiatric disorders. There are reports of
improvement of psychiatric symptoms with the absorp-
tion of retinochoroidal lesion due to toxoplasmosis [1]. In
an interesting study the reactivity for toxoplasmin intra-
dermal test, it was found to be highest in the manic
depressive patients especially in the depressed patients,
and the percentage of such patients increased with mental
deterioration [2]. Symptom of toxoplasma chorioretinitis
may masquerade as complaint of blurred vision a side
effect of psychotropics like imipramine and trifluopera-
zine [3]. Possibilities of a relationship between toxo-
plasma infection and the occurrence of schizophrenia [4]
and obsessive-compulsive disorder [5] have been sug-
gested. It has been found that the individuals with first-
episode schizophrenia had significantly increased levels
of IgG, IgM, and IgA class antibodies to toxoplasma pro-
teins, as compared with the control subjects [6]. We are
reporting a patient whose depressive syndrome may be
associated with the toxoplasmosis.
Case presentation
A 32 years old male presented with sad mood, anhedonia,
suicidal ideas, impaired sleep, loss of appetite, multiple
somatic complaints for 7 months was diagnosed to have
depressive episode and was under treatment with antide-
pressants without much benefit. His somatic complaints
were characterized by positional vertigo, tinnitus, weak-
ness, feeling that the head is moving up and down and
reeling of head. He had undergone detailed routine clini-
cal examination in ophthalmology, otorhinolaryngology,
endocrinology and neurosurgery departments for these
complaints. Specific investigation like CT scan of brain,
brainstem auditory evoked response did not show any
abnormality. His HIV status was negative. However he
was found positive on the serological test for the toxo-
plasma. He was treated with pyrimethamine and sulphad-
iazine. He was also prescribed carbamazepine 600 mg,
clonazepam 4 mg and sertraline 100 mg per day. He came
for regular follow-ups and after 6 months he was found to
have recovered completely, and free from any evidence of
toxoplasma infection.
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Conclusion
The patient responded to the antidepressant therapy after
he was treated for the toxoplasmosis. This case bringing to
the fore the toxoplasma seropositivity and non-response
to depression suggests a probable association between
toxoplasmosis and depression. Though there has been
strong indication that toxoplasmosis can be associated
with various psychiatric disorders, we do agree that for a
clearer association more accurate and rigorous proofs are
required than those presented in this communiqué.
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